Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Study of differential chromatin accessibility within primary breast epithelial cells from healthy donor and its TONSL overexpressing counterpart

ABSTRACT: Study of differential chromatin accessibility within primary breast epithelial cells from healthy donor and its TONSL overexpressing counterpart

PROVIDER: PRJNA892630 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Primary breast epithelial cells from healthy donor versus its TONSL overexpressing counterpart-enriched gene expression

Project description:Primary breast epithelial cells from healthy donor versus its TONSL overexpressing counterpart-enriched gene expression

| PRJNA892639 | ENA

Study of differential chromatin accessibility within primary breast epithelial cells from healthy donor and its TONSL overexpressing counterpart

Project description:To evaluate the probable role of TONSL during tumorigenesis we overexpressed TONSL in primary breast epithelial cells and studied differential chromatin accessibility.

2023-10-31 | GSE216237 | GEO

Primary breast epithelial cells from healthy donor versus its TONSL overexpressing counterpart-enriched gene expression

Project description:To evaluate the probable role of TONSL during tumorigenesis and to study the TONSL specific transcriptomic changes, we overexpressed TONSL in primary bresat epithelial cells and studied differential gene expression

2023-10-31 | GSE216238 | GEO

NTM & Healthy Donor Immunology & Genomics

Project description:NTM & Healthy Donor Immunology & Genomics

| PRJNA853847 | ENA

NTM & Healthy Donor Immunology & Genomics

Project description:NTM & Healthy Donor Immunology & Genomics

| PRJNA853848 | ENA

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Project description:Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.

| 2360169 | ecrin-mdr-crc

Donor Macrophages Modulate Rejection after Heart Transplantation

Project description:Cellular rejection after heart transplantation imparts significant morbidity and mortality. Current immunosuppressive strategies are imperfect, target recipient T-cells, and have adverse effects. The innate immune response plays an essential role in the recruitment and activation of T-cells. Targeting the donor innate immune response would represent the earliest interventional opportunity within the immune response cascade. There is limited knowledge regarding donor immune cell types and functions in the setting of cardiac transplantation and no current therapeutics exist for targeting these cell populations. Distinct populations of donor and recipient macrophages co-exist within the transplanted heart. Donor CCR2+ macrophages are key mediators of allograft rejection and deletion of MYD88 signaling in donor macrophages is sufficient to suppress rejection and extend allograft survival. This highlights the therapeutic potential of donor heart-based interventions.

2022-06-30 | GSE206801 | GEO

In-vitro stimulation of healthy donor blood with IL-3 cytokine

Project description:This experiment was designed to look for in vitro IL-3 gene signature in donor blood at two different time points (6 and 24 hours). RNA from lysed whole blood cells was used for the sequencing.

2018-02-02 | GSE110041 | GEO

Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

Project description:This study will evaluate the efficacy, safety, and pharmacokinetics of Trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor 2 (HER2)-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC).

| 2366623 | ecrin-mdr-crc

Individual sorted T cell profiling from healthy donor

Project description:Individual sorted T cell profiling from healthy donor

| PRJNA638939 | ENA